28mar6:00 pmFeaturedCRISPR: Out of the lab and into the clinicBroad Institute Hosted by: STAT Plus

Hosted by


Event Details

Join STAT senior writers Sharon Begley and Matt Herper for an event on the future of gene editing. They’ll sit down with the CEOs of Intellia Therapeutics, Beam Therapeutics, and CRISPR Therapeutics to discuss the latest efforts to test CRISPR in humans and to explore what new discoveries could mean for the field. STAT Plus subscribers can register for free as part of their subscription. Non-subscribers can purchase a ticket, here.


Mar. 28, 6-9 p.m.


Broad Institute

415 Main Street

Cambridge, MA

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy